1 Torres A, Cillóniz C, Blasi F, Chalmers JD, Gaillat J, Dartois N, Schmitt HJ & Welte, T. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respiratory Medicine 137 (2018), 6-13

2  Lee TA, Weaver FM, Weiss KB. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med. 2007;22(1):62-7

3 Impfplan Österreich 2022, abgerufen am 23.02.2022 unterÖsterreich.html

4 Nationale Referenzzentrale für Pneumokokken, Jahresbericht 2020, abgerufen am 15.02.2022 unter

5  Shea KM, Edelsberg J, Weycker D, et al. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014;1-9

6 Wyrwich KW, Yu H, Sato R, et al. Community-acquired pneumonia: symptoms and burden of illness at diagnosis among US adults aged 50 years and older [published online ahead of print April 3, 2013]. Patient. doi:10.1007/s40271-013-0013-4

7 Cochrane Database Syst Rev. 2017 Jan 24;1:CD001390. doi:10.1002/14651858. CD001390.pub4.Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Walters JA1, Tang JN2, Poole P3, Wood-Baker R2